
Dabur Pharmaceutical Ltd
About Dabur Pharmaceutical Ltd
Data last updated:
Dabur Pharmaceutical Ltd is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 June 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1985PLC021308.
The company has an authorised share capital of ₹2.1 Cr and a paid-up capital of ₹1.96 Cr. It was formerly known as Key Pharmaceuticals Pvt Ltd and Key Pharmaceuticals Ltd. It is led by directors including Gaurav Chamaria and Akhil Mahajan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.
The company is associated with 1 brand: Dabur. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Dabur Pharmaceutical has undergone 2 name changes throughout its history. The company was previously known as Key Pharmaceuticals Pvt Ltd, and Key Pharmaceuticals Ltd. The current legal name is Dabur Pharmaceutical Ltd.
| Company Name | Status |
|---|---|
| Dabur Pharmaceutical Ltd | Current |
| Key Pharmaceuticals Pvt Ltd | Previous |
| Key Pharmaceuticals Ltd | Previous |
Contact details
Dabur Pharmaceutical Ltd's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dabur Pharmaceutical Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dabur Pharmaceutical Ltd
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dabur Pharmaceutical Ltd, buy the company report.
Board of directors of Dabur Pharmaceutical Ltd
Dabur Pharmaceutical has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Chamaria Also directs: Super Hoze Industries Private Limited, Adisha Amara Private Limited, Absolem Technologies Private Limited and 5 more | Director | 15 May 2025 | 1 Years 6 Months | Current |
| Ram Prakash Sharma | Additional Director | 10 Nov 2025 | 1 Years 0 Months | Current |
| Akhil Mahajan Also directs: Consortium Consumercare Private Limited, A.B. Propmart Private Limited, Vertex Broadcasting Company Private Limited and 5 more | Director | 23 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Dabur Pharmaceutical Ltd is audited by JHALANI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JHALANI & CO | FY 2023 | 003675N |
Shareholding
The shareholding of Dabur Pharmaceutical Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dabur Pharmaceutical Ltd, buy the company report.
Deals & funding
Dabur Pharmaceutical Ltd has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.
Deals on record (3 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Dabur Pharmaceutical Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Dabur Pharmaceutical Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dabur Pharmaceutical Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dabur Pharmaceutical Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dabur Pharmaceutical Ltd has 14 board changes on record since 2009: 3 appointments and 11 cessations. The latest: Ram Prakash Sharma was appointed as Additional Director on 10 Nov 2025.
5 earlier events are in the company report.
Frequently asked questions
Dabur Pharmaceutical is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 June 1985 (41+ years old) and is registered under CIN U24231DL1985PLC021308.
Dabur Pharmaceutical has 3 current directors:
- Gaurav Chamaria - Director
- Ram Prakash Sharma - Additional Director
- Akhil Mahajan - Director
The latest financial statements of Dabur Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Dabur Pharmaceutical is U24231DL1985PLC021308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dabur Pharmaceutical was incorporated on 25 June 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Dabur Pharmaceutical has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹1.8 Cr; the latest was in September 2016.
Ram Prakash Sharma was appointed as Additional Director on 10 Nov 2025. Gaurav Chamaria ceased to be Additional Director on 29 Sep 2025. Gaurav Chamaria was appointed as Director on 15 May 2025. Dabur Pharmaceutical has 14 board changes on record in total.
The registered office of Dabur Pharmaceutical is at 1st Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.
Dabur Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Dabur Pharmaceutical is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.

